Francesco Novelli

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2026
The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma.

|Feb 02, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions.

Gianluca Mucciolo, Claudia Curcio, Cecilia Roux

|Oct 29, 2020
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.

Giorgia Mandili, Claudia Curcio, Sara Bulfamante

|Oct 24, 2017
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis.

M S Chattaragada, C Riganti, M Sassoe

|Jun 06, 2017
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells.

Barbara Castella, Joanna Kopecka, Patrizia Sciancalepore

|Dec 23, 2016
Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients.

Giorgia Mandili, Agata Notarpietro, Amina Khadjavi

Pageof 1

Frequent Collaborators

4 joint publications

Paola Cappello

2 joint publications

Chiara Riganti

1 joint publications

Nico Mitro

1 joint publications

Gianluca Mucciolo